# Beta-blockers in Pulmonary Arterial Hypertension

> **NCT02507011** · PHASE2 · TERMINATED · sponsor: **University of Minnesota** · enrollment: 2 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02507011
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-31
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Recruitment
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507011, "Beta-blockers in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02507011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*